Trio exome sequencing is essential when clinical findings suggest a possible genetic basis for an individual’s condition. It is often used in the following scenarios:
1. Confirming a Genetic Diagnosis: If there is a suspected genetic disorder, this test can confirm the diagnosis.
2. Guiding Treatment: Knowing the exact genetic cause helps doctors plan better treatments.
3. Reproductive Planning: If you’re thinking about having more children or have experienced recurrent miscarriages, trio exome sequencing can identify the risk factor.
4. Understanding Rare or Unexplained Diseases: Trio exome sequencing shares definite results for unexplained health problems, such as neurological symptoms like epilepsy, ataxia, or intellectual disability.
5. Understanding Disease Risk: It helps understand the risk of a genetic disease in the family and facilitates prognosis.
What is Trio Exome Sequencing?
NGS based trio exome sequencing offers a powerful approach for the identification of causal mutations for inherited disorders. Trio Exome Sequencingcan be used to identify variants inherited from the parents causing recessive disease or dominant disease. Additionally, de novo variants that occur in the offspring but are not present in either of the parents can also be detected. Trio Exome Sequencing using whole exome/clinical exome sequencing facilitates analyses of thousands of genes simultaneously to identify genetic alterations like insertions/deletions (inDels), single nucleotide variants (SNVs) and copy number variations (CNVs). This familial analysis based approach also helps in excluding variants, which do not conform to Mendelian transmission, thereby reducing false positive calls and narrowing down the potential candidate variants.Inheritance Patterns
- Autosomal Dominant mode of inheritance: Variants present in affected individuals and absent in unaffected family members. Typically, heterozygous variants are seen in affected individuals and absent in unaffected ones.
- De novo variants in the proband: Variants present only in the proband and absent in both parents. Can occur in autosomal or X-linked genes.
- Autosomal recessive mode of inheritance: Variants that are homozygous in the proband and heterozygous (carriers) in both parents, or compound heterozygous in the proband (two different heterozygous variants in the same gene, each inherited from one parent).
- X-linked mode of inheritance: X-linked mode of inheritance: Variants that are hemizygous in the affected male proband (since males have only one X chromosome) and heterozygous (carrier) in the mother. In some cases, heterozygous females can also be affected (depending on X-inactivation and variant effect).
Clinical Applications of Trio Exome Sequencing
- Unresolved Genetic Disorders: For cases where extensive testing hasn’t identified the cause.
- Reproductive Planning: Assesses recurrence risk in complex genetic disorders.
- Prognostic Insight: Offers a prognosis based on family history.
- Diagnostic Completion: Useful when no other tests confirm the diagnosis.
- Patient Management: Guides personalised treatment and prenatal diagnosis.
- Alternative for Heterogeneous Disorders: Effective for rare congenital disorders with diverse genetic causes.
Specifications
Test Methodology: Next-Generation Sequencing (NGS); Using genomic DNA extracted from blood, the coding regions of all the genes are captured and sequenced simultaneously by NGS technology on an Illumina platform. The sequence data that is generated is aligned and analysed for sequence variants.
Detectable Variants: SNVs, Insertions and deletions (InDels), and CNVs.
Test Sample: 3-5 ml blood sample in EDTA tubes, 1μg high-quality DNA, amniotic fluid and chorionic villus (CVS) sample.
Turnaround Time (TAT): 19 Working Days.
Genetic Counselling: MedGenome offers pre & post test genetic counselling with its expert and certified genetic counsellors.
Key Highlights of MedGenome's Trio Exome Sequencing
Mendelian QC Assessment
Ensures familial relationships and validates data quality using Mendelian inheritance checks.
Improved Variant Calling
Combined analysis of all three samples enhances the accuracy, even in low-coverage genomic regions.
Variant Prioritisation
Variants are carefully prioritised based on the patient’s clinical phenotype for relevance and actionability.
Get Genetic Counselling by Our Experts

Connect with Our Experts
MedGenome in the News
Please share your details to get
in touch with our experts.









